Authors: Aude Vaandering1, Nuria Jornet2, Pierfrancesco Franco3, Li Tee Tan4, Ludwig Van Den Berghe5, Sebastian Curcean6, Elena-Cristina Gheară6, Marina Iljovska7, Jana Jaal8, Timea Kirsch9, Fatjona Kraja10, Maxin Marius9, Barbara Alicja Jereczek11, Cristina Garibaldi12
1UCL Cliniques Universitaires St Luc, Department of Radiation Oncology, Brussels, Belgium; 2Medical Hospital de la Santa Creu i Sant Pau, Department of Radiation Oncology, Barcelona, Spain; 3University of Eastern Piedmont, Department of Translational Medicine (DIMET), Novara, Italy; 4Cambridge University Hospitals, Department of Oncology, Cambridge, United Kingdom; 5Ghent University Hospital, Department Radiation-Oncology, Ghent, Belgium; 6Ion Chiricuta Institute of Oncology, Department of Radiation Oncology, Cluj-Napoca, Romania; 7University Clinic of Radiotherapy and Oncology (Skopje), Department for breast and thorax malignancies, Skopje, Macedonia Former Yugoslav Republic; 8Tartu University Hospital, Clinic of Haematology and Oncology, Tartu, Estonia; 9 Ion Chiricuta Institute of Oncology, Department of Radiation Oncology, Cluj-Napoca, Romania; 10UHC “Mother Teresa”, Oncology Clinic, Tirana, Albania; 11European Institute of Oncology - University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy; 12European Institute of Oncology IEO, IRCCS, Unit of Radiation Research, Milan, Italy